TRex Bio (TRXB) files S-1 for Nasdaq IPO in the 2026 listing surge

Trex Bio filed for a Nasdaq IPO under the ticker TRXB, with Eli Lilly planning to acquire up to 19.9% stake. The company's pipeline includes TRB-071 and TRB-051, with Eli Lilly partnering on the latter. Underwriters include J.P. Morgan, Evercore ISI, and others. The IPO aims to raise capital and establish a strategic partnership with Eli Lilly.

Trex Company (TREX) raised its full-year 2026 net sales guidance to mid single-digit growth from low single-digit, citing stronger demand and operational improvements. The company expects about $1.25 billion in revenue by year-end 2026 and reaffirmed its long-term goal of $2 billion in revenue by 2030. Management highlighted growth from lower-priced products, a faster ramp at its new Little Rock plant, and strategic distribution changes.

Trex Company (TREX) reported Q2 2026 net sales of $418 million, up 8%, with gross margin at 37.9% (down from 40.8%). Adjusted diluted EPS was $0.62 and adjusted EBITDA $112 million. Full-year 2026 guidance: net sales $1.215B to $1.25B, adjusted EBITDA $335M to $350M. The company authorized $150M more buybacks and accelerated its Little Rock facility ramp-up.

Trex Company (NYSE:TREX) reported Q2 results and discussed margin pressure from a faster Little Rock production ramp, which cut gross margin by over 100 bps. Utilization improved by late June. GAAP SG&A was $67 million (16.1% of sales). Q2 free cash flow was $182 million. Trex raised 2026 guidance and forecast Q3 net sales of $305–$320 million.

Trex Company reported Q2 sales beat tied to broad demand acceleration, including a return of entry-level consumers. The company is restructuring North American distribution, ramping the Little Rock wood-conversion facility, and raised full-year 2026 adjusted gross margin guidance to 38%. Trex targets $2B revenue by 2030 and plans an additional $150M share repurchase in 2026.

Trex (NYSE: TREX) reported Q2 CY2026 revenue of $418 million, up 7.8% year on year and slightly above the $416.8 million analyst estimate. Adjusted EPS was $0.62, below the $0.63 consensus. For next quarter, Trex guided revenue to about $312.5 million and raised full-year revenue guidance to $1.23 billion at the midpoint.